SINO BIOENERGY CORP

As of September 30, 2009, SINO BIOENERGY CORP carries a market capitalization of 574,802.61, placing it among publicly traded companies globally. Its enterprise value stands at 574,564.61, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of September 30, 2009, SINO BIOENERGY CORP has 44.22M shares outstanding.

These figures are as of September 30, 2009.

As of September 30, 2009, SINO BIOENERGY CORP maintains a current ratio of 0.00, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended September 30, 2009. Return on assets (ROA) is negative at -269.41, reflecting losses generated across the asset base.

As of the close on October 12, 2026, SINO BIOENERGY CORP's stock has declined approximately 33.33% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.01.

These figures cover the twelve months ended September 30, 2009. EBITDA reached -798,299.00, while operating income came in at -867,660.00.

These figures are as of September 30, 2009. Total book value stands at -676,747.00, with working capital of -676,747.00 providing operational flexibility.

SINO BIOENERGY CORP produced -1.57M in operating cash flow over the twelve months ended September 30, 2009.

These figures cover the twelve months ended September 30, 2009. Free cash flow yield is negative at -315.93: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow.